Adrenergic-Blocking Drugs
... Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. ...
... Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. ...
Licorice - Glycyrrhiza glabra
... Scientists have shown that licorice has an effect on the adrenals, helping to stimulate glucocorticoid production. In excess, this leads to the side effects now recognized for licorice. Recognizing these effects described for and related to licorice, Riccardo Baschetti of Padova, Italy, sent a lette ...
... Scientists have shown that licorice has an effect on the adrenals, helping to stimulate glucocorticoid production. In excess, this leads to the side effects now recognized for licorice. Recognizing these effects described for and related to licorice, Riccardo Baschetti of Padova, Italy, sent a lette ...
Migraine — Current Understanding and Treatment
... 20 percent have attacks lasting two to three days.12 Thus, 5 percent of the general population have at least 18 days of migraine per year, and at least 1 percent — that is, more than 2.5 million persons in North America — have at least 1 day of migraine per week. The lifetime prevalence of migraine ...
... 20 percent have attacks lasting two to three days.12 Thus, 5 percent of the general population have at least 18 days of migraine per year, and at least 1 percent — that is, more than 2.5 million persons in North America — have at least 1 day of migraine per week. The lifetime prevalence of migraine ...
Combined use of nonsteroidal anti-inflammatory drugs with diuretics
... and end-stage kidney disease and death.1 Nonsteroidal antiinflammatory drugs (NSAIDs) are estimated to account for up to 7% of all cases of AKI and up to 36% of drug-induced cases.2,3 NSAID exposure has been reported to increase the risk of AKI between 1.3- and 4.1-fold and the number needed to harm ...
... and end-stage kidney disease and death.1 Nonsteroidal antiinflammatory drugs (NSAIDs) are estimated to account for up to 7% of all cases of AKI and up to 36% of drug-induced cases.2,3 NSAID exposure has been reported to increase the risk of AKI between 1.3- and 4.1-fold and the number needed to harm ...
Product Monograph Template - Standard
... linked to the treatment per se [e.g., protease inhibitors (PIs)], and in part to disease control and life style. New onset diabetes mellitus, exacerbation of pre-existing diabetes mellitus, and hyperglycemia have been reported during post-marketing surveillance in HIV-1 infected patients receiving P ...
... linked to the treatment per se [e.g., protease inhibitors (PIs)], and in part to disease control and life style. New onset diabetes mellitus, exacerbation of pre-existing diabetes mellitus, and hyperglycemia have been reported during post-marketing surveillance in HIV-1 infected patients receiving P ...
Prescribing Guide/Formulary 2014 - City Hospitals Sunderland NHS
... medicines are routinely available to prescribe on EP, but use of some may be restricted. Medicines in the formulary are listed in chapters and subsections that generally correspond with those in the British National Formulary (BNF). Recommended International Non-proprietary Names (INNs) are used thr ...
... medicines are routinely available to prescribe on EP, but use of some may be restricted. Medicines in the formulary are listed in chapters and subsections that generally correspond with those in the British National Formulary (BNF). Recommended International Non-proprietary Names (INNs) are used thr ...
[Salvia divinorum - a potential drug for abuse]
... humans (Siebert DJ, 1994). Additionally, given that its pharmacological action (kappa-opioid receptor agonist) is quite unique compared to other hallucinogens (some of which act via the serotonin 5-HT receptor), salvinorin A's long-term effects remain to be established. Therefore, the risks of Salvi ...
... humans (Siebert DJ, 1994). Additionally, given that its pharmacological action (kappa-opioid receptor agonist) is quite unique compared to other hallucinogens (some of which act via the serotonin 5-HT receptor), salvinorin A's long-term effects remain to be established. Therefore, the risks of Salvi ...
Airway Mgt of the Critically Ill Patient
... which result in postintubation hypotension.40 Endotracheal intubation also can provoke bronchospasm and coughing that may aggravate underlying conditions, such as asthma, intraocular hypertension, and intracranial hypertension. Patients who are at risk for adverse events from airway manipulation ben ...
... which result in postintubation hypotension.40 Endotracheal intubation also can provoke bronchospasm and coughing that may aggravate underlying conditions, such as asthma, intraocular hypertension, and intracranial hypertension. Patients who are at risk for adverse events from airway manipulation ben ...
Terbinafine and smell alterations Introduction Reports
... there were only taste disturbances, in 2 cases only smell disturbances and in one case both taste and smell disturbances existed. Mean age of the patients was 53, 13 patients were females. The median time to event onset was 24 days (range 4– 95 days). In six cases the ADR led to treatment discontinu ...
... there were only taste disturbances, in 2 cases only smell disturbances and in one case both taste and smell disturbances existed. Mean age of the patients was 53, 13 patients were females. The median time to event onset was 24 days (range 4– 95 days). In six cases the ADR led to treatment discontinu ...
Ritalin LA - Novartis Pharmaceuticals Corporation
... problems. Adults with such abnormalities should also generally not be treated with stimulant drugs. Hypertension and Other Cardiovascular Conditions Stimulant medications cause a modest increase in average blood pressure (about 2-4 mmHg) and average heart rate (about 3-6 bpm), and individuals may ha ...
... problems. Adults with such abnormalities should also generally not be treated with stimulant drugs. Hypertension and Other Cardiovascular Conditions Stimulant medications cause a modest increase in average blood pressure (about 2-4 mmHg) and average heart rate (about 3-6 bpm), and individuals may ha ...
WELLBUTRIN® (bupropion hydrochloride) Tablets
... It is generally agreed that acute episodes of depression require several months or longer of antidepressant drug treatment beyond the response in the acute episode. It is unknown whether the dose of WELLBUTRIN needed for maintenance treatment is identical to the dose that provided an initial respons ...
... It is generally agreed that acute episodes of depression require several months or longer of antidepressant drug treatment beyond the response in the acute episode. It is unknown whether the dose of WELLBUTRIN needed for maintenance treatment is identical to the dose that provided an initial respons ...
STEROID PROFILES (Anabolic Emporium)
... assess tolerance. Trying this for the first time 2 weeks before a competition can be disastrous. A 220lb man is 100kg exactly. This means that if he is a first time user of crystalline DNP then he should take 200mg per day. I suggest staying with this dose for at least 3 days to keep it safe, then s ...
... assess tolerance. Trying this for the first time 2 weeks before a competition can be disastrous. A 220lb man is 100kg exactly. This means that if he is a first time user of crystalline DNP then he should take 200mg per day. I suggest staying with this dose for at least 3 days to keep it safe, then s ...
ANNEX I TO PSUR CORE SAFETY PROFILE (EU SPC Sections 4.2
... midazolam after rectal and intramuscular administration. It is expected that these interactions will be less pronounced for the rectal than for the oral route because the gastro-intestinal tract is by-passed whereas after IM administration the effects of CYP3A4 modulation should not substantially di ...
... midazolam after rectal and intramuscular administration. It is expected that these interactions will be less pronounced for the rectal than for the oral route because the gastro-intestinal tract is by-passed whereas after IM administration the effects of CYP3A4 modulation should not substantially di ...
doc - National Bureau of Economic Research
... questions about whether the ED has a computerized system for orders for prescriptions or for lab tests, but was added as a separate item following that entire section. Therefore, there was no skip pattern to link responses to this question with the previous two questions. Because of the independence ...
... questions about whether the ED has a computerized system for orders for prescriptions or for lab tests, but was added as a separate item following that entire section. Therefore, there was no skip pattern to link responses to this question with the previous two questions. Because of the independence ...
An Overview of the Biological Effects of Focused Ultrasound Abstract
... of carrier vehicles such as microbubbles, liposomes, and nanoparticles. Release of drugs from microbubbles (i.e. ultrasound contrast agents) can be readily monitored in real time using ultrasound imaging. If drugs are coupled to MRI contrast agents, MRI can also be used for monitoring. With the use ...
... of carrier vehicles such as microbubbles, liposomes, and nanoparticles. Release of drugs from microbubbles (i.e. ultrasound contrast agents) can be readily monitored in real time using ultrasound imaging. If drugs are coupled to MRI contrast agents, MRI can also be used for monitoring. With the use ...
Two Decades Coordinating Medication Safety Efforts
... culture, the definition of a medication error, patient populations served, and the type(s) of reporting and detection systems used. Health care organizations should continuously monitor actual and potential errors and investigate the root causes of errors to identify ways of improving the medication ...
... culture, the definition of a medication error, patient populations served, and the type(s) of reporting and detection systems used. Health care organizations should continuously monitor actual and potential errors and investigate the root causes of errors to identify ways of improving the medication ...
Télécharger le fichier - Fichier
... each drug for any change in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new or frequently employed drug. Some drugs and medical devices presented in this publication have Food and Drug Administration (FDA) clearance fo ...
... each drug for any change in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new or frequently employed drug. Some drugs and medical devices presented in this publication have Food and Drug Administration (FDA) clearance fo ...
Drug treatments for Parkinson`s booklet Word version
... and error. But once the right combination is found for your symptoms, the drug treatment for Parkinson’s is very good.” Steve, diagnosed in 1999 Research has led to a range of different medications that are now available for Parkinson’s that can help manage or reduce symptoms, such as tremor or prob ...
... and error. But once the right combination is found for your symptoms, the drug treatment for Parkinson’s is very good.” Steve, diagnosed in 1999 Research has led to a range of different medications that are now available for Parkinson’s that can help manage or reduce symptoms, such as tremor or prob ...
product monograph serc
... The safety and efficacy of SERC® in pediatric patients below 18 years of age have not been evaluated, therefore its use in this population is not recommended. Geriatrics (> 65 years of age) Limited data from clinical studies suggest that a dosage adjustment is unlikely to be required in this patient ...
... The safety and efficacy of SERC® in pediatric patients below 18 years of age have not been evaluated, therefore its use in this population is not recommended. Geriatrics (> 65 years of age) Limited data from clinical studies suggest that a dosage adjustment is unlikely to be required in this patient ...
Serotonin Syndrome
... syndrome has been reported in patients with endstage renal disease who are on selective serotonin reuptake inhibitors (SSRIs) and hemodialysis. These patients are prone to developing serotonin toxicity, suggesting that this increased toxicity could be related to a decrease in renal functioning.5 An ...
... syndrome has been reported in patients with endstage renal disease who are on selective serotonin reuptake inhibitors (SSRIs) and hemodialysis. These patients are prone to developing serotonin toxicity, suggesting that this increased toxicity could be related to a decrease in renal functioning.5 An ...